Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Primary antibodies included anti--Catenin, anti-GSK3, anti-phospho-GSK3, anti-GAPDH, and anti--tubulin (Boster Biological Technology, Pleasanton, CA, United States), anti-Bcl2, anti-Bax, and anti-Cyclin D1 (Abcam plc, Cambridge, United Kingdom), anti-Akt and anti-phospho-Akt (Cell Signaling Technology, Danvers, MA, United Ststes), anti-Wnt10b, anti-CDK2, anti-CDK4, and anti-P21 (ABclonal, Wuhan, China), and anti-ki67 (Proteintech, Wuhan, China)
CDI Query Templates The following query templates are AHIMA/ACDIS-compliant, non-leading, and offer multiple-choice options per AHIMA Practice Brief: Guidelines for Achieving a Compliant Query Practice (2019 Update)
With injectable compounds, the documentation is not a nice-to-have
Activation of these receptors is reported to slow gastric emptying and enhance satiety signaling, reducing food intake
US$ 29.39
US$ 26.95
US$ 29.56
US$ 22.62
US$ 29.83
US$ 23.96
US$ 25.47
US$ 26.00
